We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Six generics manufacturers are to face trial over official allegations of a GBP100mn (US$182.22mn) price-fixing fraud involving UK healthcare provider the National Health Service (NHS).
According to official data, China's top 100 drug companies registered sales of CNY93.63bn (US$11.57bn) in H105, representing 47.4% of the industry total.
Chiasma Inc., a developer of an innovative platform technology for oral delivery of macromolecule drugs, has announced the completion of a $6.2 million Series B financing round.
About a dozen senior executives with six British-based drug companies, including the Indian Ranbaxy's UK unit, are reportedly likely to face trial on charges by Christmas, of conspiring to defraud the National Health Service of more than £100 million by allegedly rigging the prices for some of the most commonly used drugs.
Pan Pharmaceuticals head Jim Selim failed on four occasions to disclose to his directors that one of its products had been recalled by the national medicines watchdog, a court has heard.
Bayer Pharmaceuticals Corp and Onyx Pharmaceuticals Inc announced that Bayer has submitted an application for EU approval of their sorafenib cancer treatment to the European Medicines Agency (EMEA) in London.
RioTech Pharmaceuticals Limited (RioTech Pharma) today announced that it has successfully raised GBP750,000 (over $1.3 million) in a private financing round.
Lincoln Pharmaceuticals Ltd., a midsize drug maker, said Monday that the company has bagged export order worth Rs.50 million ($1.14 million) from Heko Pharmacy Ltd. of Tanzania.
A number of European countries, led by the UK, have launched a US$4bn
inoculation scheme to provide vaccines for children in Africa and other low-income regions.